various oncological diseases
Conditions
Interventions
Group 1: Children/adolescents in whom an additional dose-neutral attenuation correction (LSO-TX) is performed on clinically indicated PET/CT for CT-based attenuation correction.
Group 2: Children/adol
Sponsors
Radiologische Universitätsklinik Tübingen, Abteilung für Diagnostische & Interventionelle Radiologie
Eligibility
Sex/Gender
All
Age
No minimum to 17 Years
Inclusion criteria
Inclusion criteria: Children/adolescents <18 years of age who have undergone a whole-body MRI and are to undergo a PET scan with the Biograph Vision Quadra for clinical indications (usually staging and restaging, risk stratification for malignant tumours), or children/adolescents aged <18 years who are to undergo a clinically indicated PET/MRI and who also require a high-contrast, low-dose CT scan of the lungs and bones for clinical indications, or children/adolescents aged <18 years who are to undergo a clinically indicated PET scan, but who also require a low-dose CT scan for morphological classification of the expected findings. In addition, written consent should always be obtained from the legal guardian and, if appropriate, the child.
Exclusion criteria
Exclusion criteria: pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of three different radiation-free methods for attenuation correction of long-axial field PET/CT in pediatric patients (LSO-TX, MR-Reg, Synthetic-AI CT) | — |
Secondary
| Measure | Time frame |
|---|---|
| Establishment of PET measurement protocols for pediatric patients without CT-induced dose | — |
Countries
Germany
Contacts
Public ContactJürgen Schäfer
Radiologische Universitätsklinik Tübingen, Abteilung für Diagnostische & Interventionelle Radiologie
Outcome results
None listed